HOME >> BIOLOGY >> NEWS
Ethical guidelines needed before 'nutrigenomic' groceries come to market

enlarging already huge inequities in health status and disease burden both within developed nations, and especially between developed and developing countries.

If nutritional genomics testing turns out to be valuable for health care, there will be pressure on governments to fund the tests. As a general principle, the higher the predictive value of the nutrigenetic test, and the more effective known interventions are, the clearer the practitioner's duty to offer the test and society's obligation to fund it.

Regulation and oversight

Governments are looking at what if any regulations are needed to cover issues in this field, including scientific research, consent, counseling, testing technology and standards, who gets to provide nutritional genomics services, and access to nutritional genomics information.

Governments have a wide range of options. The most open would be to leave the issue to the market, as is now the case for home pregnancy testing kits or genetic testing to establish parentage. Moving up a step, governments could require or professional groups or the industry could unilaterally establish voluntary codes of practice. The most severe level of would be strict regulation, similar to that covering prescription drugs or HIV testing. This level might be applied only to testing that has a high potential psychological impact on a person or that requires extensive analysis or interpretation.

As nutritional genomics research zeroes in on more specific links between specific foods and diseases, the line between foods and drugs may become more blurred. This could pose challenges for governments, which have tended to regulate food and drugs differently. Governments are already grappling with what health benefits foods should be permitted to claim, and how these claims should be communicated to the public.

Because some of these "foods" make claims that enter the terrain traditionally limited to drugs, governments n
'"/>


3-Nov-2003


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
2. New guidelines show significant benefits of FUZEON for wide range of pre-treated HIV/AIDS patients
3. International critical care doctors release first-ever guidelines for sepsis
4. Revised guidelines published for testing for hereditary type of colorectal cancer
5. New ACOG guidelines on progesterone to prevent preterm birth praised by March of Dimes
6. New guidelines can help health officials better predict and control dengue epidemics
7. Researchers develop guidelines to establish identity of genes responsible for complex diseases
8. Aborigine study suggests body mass index guidelines should be lower to block diabetes
9. New nutrition guidelines for diabetics promote emphasis on high-monounsaturated fat diet
10. Conservation International and Starbucks announce new coffee sourcing guidelines
11. Report on dietary supplements containing ephedra makes urgent call for research to develop dose guidelines, safety warnings

Post Your Comments:
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint Cards ... FPC1035, FPC1145 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... sensors will be used by smartphone manufacturers in ... included in the communicated revenue guidance of approximately 2,200 MSEK ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/6/2015)... -- Research and Markets ( ... "Biotechnology for the Non-Biotechnologist" conference to ... ideal for non-Scientists and Scientists needing to understand ... biotechnology. Ideal for Non-Scientists and Scientists ... and potential of biotechnology Why you ...
(Date:7/6/2015)... 6, 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company ... , Viveve,s Chief Executive Officer, and Scott Durbin , ... July 9, 2015. , , , DATE:    ... , , TIME:     , , , 12:15 PM ... , http://tinyurl.com/viveve   ,    ...
(Date:7/6/2015)... PRINCETON, N.J. , July 6, 2015 Navitas, a leading ... Latin America hub in Bogota, Colombia ... advantage of the many benefits provided by Colombia , ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... location, allows US based clients to communicate with Navitas regulatory ...
(Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
Breaking Biology Technology:Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
Cached News: